145.85
+0.35
+(0.24%)
At close: April 11 at 4:59:32 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 3 |
| Avg. Estimate | 0 | 0 | 16 | 11.6 |
| Low Estimate | 0 | 0 | 11.9 | 8.41 |
| High Estimate | 0 | 0 | 20.1 | 15.7 |
| Year Ago EPS | -- | 3.3 | 12.6 | 16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 6.51B | 5.6B |
| Low Estimate | -- | -- | 6.4B | 5.09B |
| High Estimate | -- | -- | 6.62B | 5.95B |
| Year Ago Sales | -- | -- | 5.72B | 6.51B |
| Sales Growth (year/est) | -- | -- | 13.86% | -13.96% |
Earnings History
| Currency in DKK | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 2.7 | 7.52 | 13.65 | 8.2 |
| EPS Actual | -1.5 | 3.3 | 0.9 | 9.9 |
| Difference | -4.2 | -4.22 | -12.75 | 1.7 |
| Surprise % | -155.56% | -56.12% | -93.41% | 20.73% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 16 | 11.6 |
| 7 Days Ago | 0 | 0 | 11.9 | 12.07 |
| 30 Days Ago | 0 | 0 | 11.9 | 12.09 |
| 60 Days Ago | 0 | 0 | 19.62 | 12.03 |
| 90 Days Ago | 0 | 0 | 21.8 | 13.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BAVA.CO | -- | -- | 26.98% | -27.48% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Related Tickers
GMAB.CO Genmab A/S
1,225.00
+0.66%
ZEAL.CO Zealand Pharma A/S
427.70
-0.28%
GUBRA.CO Gubra A/S
377.00
+1.07%
ALK-B.CO ALK-Abelló A/S
140.60
+2.33%
GMAB Genmab A/S
18.81
+4.44%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
19.58
0.00%
EVAX Evaxion Biotech A/S
1.3500
+0.75%
SANION.ST Saniona AB (publ)
6.72
-0.59%
HNSA.ST Hansa Biopharma AB (publ)
21.88
-1.08%
FLUI.ST Fluicell AB (publ)
12.22
-3.63%